Pfizer Sues Over Generic For Arthritis Drug Xeljanz
Pharmaceutical giant Pfizer has asked a Delaware federal court to block generic-drug maker Aurobindo Pharma from moving ahead with plans to sell a generic version of arthritis drug Xeljanz that Pfizer...To view the full article, register now.
Already a subscriber? Click here to view full article